Express News | Medicus Pharma Shares Are Trading Higher After the Company Its INAD File No.013880 Was Used as Part of a Major Species Designation From the FDA

BenzingaDec 12 08:27 ET

Medicus Pharma up 9% in Pre-market Trading as FDA Approves Anti-cancer Patch for Horses

MT NewswiresDec 12 08:18 ET

Medicus Pharma Eyes Veterinary Market With FDA Designation

TipRanksDec 12 08:07 ET

Express News | Medicus Pharma Says INAD File No.013880 Received Minor Use In Major Species Designation From FDA For Its Dissolvable D-MNA To Treat External Squamous Cell Carcinoma In Horses

BenzingaDec 12 07:47 ET

Medicus Pharma Announcs Its INAD Received MUMS From U.S. FDA

TipRanksDec 12 07:36 ET

Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation From the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch

newsfileDec 12 07:30 ET